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One of the treatments for recurrent or complicated osteomyelitis is by local antibiotherapy 
mediated by suitable bone grafts. β–Tricalcium Phosphate (β–TCP) bioceramic is a resorbable 
bone graft. Its microporosity allows for incorporation of drugs, but a too fast release is often 
obtained. Complex strategies have been explored to obtain controlled drug release. In this 
work, plasma polymerization of a biocompatible polymer was investigated on β-TCP. 
Polyethyleneglycol (PEG)-like polymer coatings of different thickness were deposited on 
microporous β-TCP loaded with antibiotics. A highly hydrophobic surface was obtained 
despite the hydrophilicity of the PEG-like layer produced, which was associated to the 
roughness of the β-TCP substrate. The bioceramics nevertheless retained their suitable 
biological behavior with regard to human osteoblast cells. The microbiological activity of the 
antibiotics was preserved, and the coatings reduced the total amount of drug released as a 
function of the increasing plasma treatment time. 




Osteomyelitis is a bone infection. It can spring from different causes: i) from spreading 
of bacteria originating from an infection elsewhere in the body, ii) through an open wound 
over a bone or iii) after the exposure of bone to bacteria during a surgery or an injection 
around a bone. The most usual treatments involve administration of antibiotics, but some- 
times surgery may be necessary, and whenever bone is damaged it requires removal and 
replacement with a bone graft [1] Systemic antibiotic regimes are used for four to eight weeks 




Email  addresses:   cristina.canal@upc.edu (Cristina Canal) 
February 16, 2018  
 
 
diagnosis or treatment, significant bone damage; or if the initial treatment is not effective, 
patients are more prone to reoccurrence and the condition can become chronic and difficult 
to eradicate [2, 3]. 
The delivery and maintenance of therapeutic levels of antibiotic at the site of infection can 
be achieved by using implants or carriers that release antibiotics locally; these have 
significantly improved the treatment of osteomyelitis [4]. Many local antibiotic releasing 
systems have been developed in recent years, and several are available for clinical use, such as 
polymethylmethacrylate (PMMA) beads, collagen, apatite-wollastonite glass ceramic blocks, 
hydroxyapatite blocks, polylactide/polyglycolide implants, and polylactate polymers [3, 5–7]. 
Among these PMMA rosary beads impregnated with gentamicin have been often employed in 
the clinics, but they have several disadvantages, especially the need to remove the foreign 
material surgically under general anaesthesia [5, 6, 8–10].  
An ideal local carrier should be biocompatible and biodegradable, and in applications 
requiring bone substitution, it should be resorbable and able to promote bone formation. Many 
calcium phosphates (CaPs) have been widely employed as bone grafts and many of them are 
in the market. Among them, β–tricalcium phosphate (β–TCP) is an interesting bioceramic 
obtained at high temperatures with higher solubility than i.e. hydroxyapatite and that has been 
widely employed in reconstructive surgery [11] due to its resorbability and ability to promote 
new bone formation [12–14].  
β-TCP has been evaluated as drug delivery system of different drugs. For example, in the 
release of gentamicin fast release was obtained in the first day and different strategies, more or 
less complex were evaluated to control this release [15]. Different works have relied in 
producing composite materials from β-TCP or other CaPs and biocompatible polymers (such 
as chitosan, gelatin, etc.) [16, 17]; to improve different features of the material, among which 
to modulate drug release from the matrices. However, this approach usually involves complex 
processing stages. Plasma polymerization is a versatile technique for the deposition of films 
with functional properties suitable for a wide range of applications [18, 19]. Although plasma 
polymerization is a well-studied field, its application to bioceramics is rather recent. In a recent 
work, we proposed plasma polymerization of a hydrophilic polyethyleneglycol (PEG)-like 
layer as a dry method allowing to coat β-TCP [20]. In that work, the coating produced allowed 
to successfully modify drug release kinetics, avoiding burst release, and slowing down the 
initial rate of release. However, the coatings produced by plasma polymerization led to very 
hydrophobic surfaces. This change in wettability could have a critical impact on the biological 
behaviour of these bioceramics.	
Herein, we aim at investigating in-depth the origins of this unexpected hydrophobicity, with 
a particular focus on its effects on biological behaviour. Therein, β-TCP has been subjected 
to plasma polymerization to obtain PEG-like coatings, by using single and multi- step 
coatings, and the modified surfaces have been characterized. To ascertain the barrier effect of 
the coatings developed, the release of two different antibiotics (gentamicin and ampicillin) 
has been evaluated from these bioceramics, and their microbiological behaviour has been 
studied after the plasma polymerization process undergone by the samples. 
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2. Material and methods 
2.1. Materials 
Calcium hydrogen phosphate (CaHPO4, Sigma-Aldrich C7263) and calcium carbonate 
(CaCO3, Sigma-Aldrich C4830) were used as raw materials for the synthesis of β–tricalcium 
phosphate (β-Ca3(PO4)2, β–TCP). Sodium phosphate dibasic (Na2HPO4, Sigma-Aldrich) was 
used in solution as accelerant in the synthesis of calcium deficient hydroxyapatite (CDHA) 
used as a precursor of β–TCP. Ampicillin sodium salt (371.39 g/mol; 50mg/ml    in water), 
and gentamicin sulphate (477.6 g/mol, 50mg/ml in water) provided by Sigma- Aldrich were 
selected as antibiotics for loading β–TCP ceramics (supplementary material Figure S1). 
Diethylene glycol dimethyl ether (Diglyme, anhydrous, 99.5%, Sigma Aldrich) 
(CH3OCH2CH2)2O was used as precursor for plasma polymerization. Phosphate buffer saline 
(PBS), pH 7.4, was prepared from PBS Tablets  (Gibco,  LifetechnologiesTM,  UK)  and  Milli-
Q® deionized  water.  Agar bacteriological (Scharlau S.A., Spain) and Brain Heart Infusion 
Broth (BHI Broth) (Scharlau S.A., 02-599, Spain) were used to prepare the bacteriological 
culture media of Staphylococcus aureus (S. aureus), (Culture Collection University of 
Göteborg (CCUG 15915), Sweden). 
2.2. β-TCP Synthesis 
Microporous β–TCP discs were obtained by thermal treatment of calcium deficient 
hydroxyapatite (CDHA), which was in turn obtained through the setting reaction of an α–
TCP calcium phosphate cement. α–TCP was obtained by solid state reaction of a 1:2 
molar mixture of calcium hydrogen phosphate and calcium carbonate at 1400 ºC. A cement 
was produced by blending α–TCP with a solution of sodium phosphate dibasic at 2.5% 
(w:w) at liquid to powder ratio of 0.65. The mixture was put in a disc-shaped mould and 
allowed to set immersed in water for 7 days to obtain CDHA, as described in [21]. The 
former discs were sintered at 1100 ºC to obtain microporous β–TCP discs of 2 mm 
thickness 12 mm ø. This allowed obtaining a 100% β-TCP material, according to XRD (not 
shown). 
2.3. Plasma  Polymerization 
Plasma polymerization of β–TCP discs was performed using low-pressure radio-frequency 
plasma (13.56 MHz) (Standard Femto Plasma System, Diener, Germany) with a cylindrical 
glass chamber. Diglyme was used as source of ethylene oxide monomers to obtain a PEG-
like coating on β–TCP [22]. Unloaded or antibiotic-loaded β -TCP discs were placed in the 
centre of the reactor. To enhance the polymerization process a short surface activation step 
with O2 (5.0 sccm, 0.40 mbar, 150 W) was performed for 60 s. The subsequent polymerization 
process consists in introducing Diglyme in the plasma reactor by bubbling a carrier gas (Ar) 
through the liquid monomer. The polymerization treatment performed in continuous mode 
(15 sccm, 1.70 mbar, 150 W) for 10 min is labelled as plasma polymerization (PP10). 
Repetition of  the polymerization cycle in the same conditions described, without removing 
the samples from the reactor was designed for 20 min, 30 min or 40 min polymerizations were 
performed on each side of the β–TCP materials, and the corresponding samples were 
referenced as PP20, PP30  and  PP40 respectively (Figure 1). 
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2.4. Surface Topography 
Topography of untreated and plasma polymerized β–TCP discs were studied by Scanning 
Electron Microscopy using a Zeiss Neon 40 cross-beam workstation with Gemini SEM 
column for sample observation. Samples were carbon-coated before SEM observation. 
Observations were carried out at 5.0 kV working voltage. Coupled-Energy-Dispersive X-ray 
spectroscopy (EDX) equipment (INCAPentaFETx3 detector, 30 mm2, ATW2 window) was 
also used for in situ elemental analysis of the surface of a cross-section of plasma-polymerized 
β–TCP to determine the depth of the effects of plasma treatment on the surface of the bio- 
ceramic materials. 
2.5. Wetting Properties 
Determination of the wettability of the β–TCP surfaces, to compare the untreated with the 
PEG-coated ceramics by plasma polymerization was done by static and dynamic contact angle 
measurements. A Contact Angle System OCA15 (Dataphysics, Germany) was used with the 
SCA20 Software (Dataphysics, Germany) to analyse the images acquired with a CCD. In 
static, 10 µL water droplet were deposited on the β–TCP surface and in dynamic, volume 
changes continuously. Measurements were carried out on the plasma-polymerized side of the 
samples. In this study, a minimum of 5 replicates of each kind of treatment were carried out. 
Dynamic contact angles were calculated as follows: Advancing contact angles were 
measured by increasing the volume of the water drop, until the contact angle remained 
constant. Receding contact angles were measured by decreasing the volume of the drop until 
the con- tact angle value remained constant and the solid/liquid interface started to decrease. 
Values reported result from the average of at least 6 replicates measured in independent 
samples. 
The contact angle hysteresis was calculated as the difference between dynamic advancing 
and receding contact angles, according to equation 1. 
Δθ  =  θadv  − θrec                                                           Eq.1 
2.6. Chemical Characterization 
To determine the chemical composition of the surface of bare and treated β–TCP samples 
and assess the influence of plasma polymerization, X-ray photoelectron spectroscopy (XPS) 
experiments were performed with a ESCALab MKII spectrometer by Vacuum Generators 
using non-monochromatic Al-Kα radiation (photon energy 1486.6 eV) in normal emission 
mode (i.e. photoelectrons were detected along the surface normal of the samples). Survey 
spectra were recorded at reduced energy resolution at pass energy of 50 eV, while the detail 
spectra of C1s, Ca2p, Ca2s, P2p, P2s and O1s were recorded at pass energy of 10 eV.  For estimating 
the distribution   of elements in terms of at -% the intensity of the photoemission peaks (as 
obtained after Shirley-type background correction) were weighted with the photoemission 
cross sections. The relative error associated to the XPS measurements is about 5%. 
Fourier Transform Infrared Spectra were recorded using a FTIR Nicolet 6700 in the 
transmittance mode, (128 scans and resolution 1 with data spacing 0.482cm−1). Si wafer were 
used as the substrate instead of β–TCP disc for the FTIR measurement. 
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2.7. Ampicillin and Gentamicin Loading of β–TCP 
Loading of ampicillin and gentamicin was done prior to plasma polymerization; by 
soaking the β–TCP discs in 1.0 mL of 4.0% aqueous drug solution at 100 r.p.m. and 24 - 27 
ºC during 30 min, by complete immersion of the sample. Samples were dried at 37 ºC for 24 
h prior to release studies.  
2.8. Drug Release Experiments 
Ampicillin and gentamicin release experiments were performed using untreated and 
plasma-polymerized β–TCP discs previously loaded with the 4.0% solution of drugs 
respectively. Details of the amount of drug loaded in each kind of samples devoted to drug 
release are provided in supplementary material (Table S1). The assay included samples loaded 
with drug (D) (ampicillin (AMP) or gentamicin (GENTA): UT-D; PP10-D, PP20-D, PP30-D 
and PP40-D) and untreated samples. For the drug release study, an USP equipment (TDT-
08L Dissolution Tester (USP), Pharma Alliance Group, U.S.A.) with 8 thermo- jacketed 
opaque cells of 300 mL was used, each one filled with 150 mL of PBS at pH 7.4 as receptor 
media. Temperature and rotation were maintained constant at 37 ºC and 100 r.p.m. 
respectively. 1 mL samples were withdrawn from the receptor liquid media for release 
concentration analysis from the untreated and plasma-polymerized β–TCP discs. After each 
sample withdrawn, the same volume of PBS was added to the receptor media. Release 
experiments were performed with four replicates of each plasma polymerization condition. 
For the quantification of the ampicillin release, an UV-visible-NIR spectrophotometer 
UV-3600 Shimadzu was used at λ = 204 nm, corresponding to the wavelength of maximum 
absorbance of ampicillin in PBS solution. The concentration of ampicillin was below 10% 
saturation concentration (SINK conditions) in the receptor solution during the experiment. 
Stability of ampicillin after plasma polymerization on the ampicillin-loaded β–TCP was also 
checked by UV- spectroscopy after release of ampicillin in PBS through comparison of the 
general spectra. The amount of gentamicin released was obtained by measuring the release 
media collected at each time point by High Performance Liquid Chromatography (HPLC) in   
a Shimadzu HPLC system. Mobile phase consisted of methanol–water–ammonium acetate 
buffer (0.02M, adjusted with concentrate ammonia to pH = 9): 35:60:5 (v/v/v), at a flow rate 
of 0.3 ml/min was passed through a C8 column (Shim-pack, Shimadzu). An injection volume 
of 20 µl of the release sample was measured by photodiode array (PDA) at λmax= 238 nm 
corresponding to the wavelength of maximum absorbance of gentamicin in PBS solution. 
Stability of gentamicin after plasma polymerization on the gentamicin-loaded β–TCP was 
also checked by HPLC after release of gentamicin in PBS through comparison of the control 
spectra. 
The kinetic models used were Zero order equation (Qt = Q0 – K0t) and Kopcha kinetics 
(Qt = At1/2 + Bt) [Q0 is the initial amount of drug in the solution Q0= 0, K0 is the zero order 
release constant and Qt is the amount of drug released at time t, A = diffusional constant 
and B = erosion constant]. 
2.9. Antibacterial Assay 
The antibacterial activity of the ampicillin and gentamicin loaded plasma polymerized β- 
TCP discs were tested in suspension against Staphylococcus aureus (S. aureus) in BHI Broth 
at [BHI] = 37.0 g. L−1. After incubation for 24 h at 37 ºC, 1 mL of the inoculate media was 
put in each well of a 48-well FalconTM culture well-plates, previously prepared by connecting 
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two adjacent wells.  The optical density of bacterial suspension was adjusted to 0.2 ± 0.01 at 
600nm, giving approximately 1 x 108 colony-forming units (CFU)/ml. The assay was 
conducted with samples loaded with drug (D) (ampicillin (AMP) or gentamicin (GENTA): 
UT-D; PP10-D, PP20-D, PP30-D and PP40-D) and samples without antibiotics that were 
treated as controls (untreated β-TCP: UT, untreated β-TCP with 40 min polymerization: PP40 
Samples) apart from controls of S. aureus Ctrl+ (with bacteria) and Ctrl- (bacteria growth 
medium without bacteria). Later, samples were placed in one of the connected wells, while 
the second was employed to measure absorbance and monitoring the growth of S. aureus by 
means of a Synergy HTX Multimode Reader (BioTek Instruments, Inc.).  The antibacterial 
growth kinetics was monitored for 48 h at λ=600 nm absorbance [23]. Measurements were 
recorded using Gen. 5 software (BioTek Instruments, Inc.) and results are presented in growth 
curve with standard deviation. 
2.10. Cell Biocompatibility 
The effect of the plasma coating on β-TCP discs on the interaction with osteoblastic  cells 
was evaluated using a human osteosarcoma cell line (SaOS-2, ATCC, USA), with three 
replicates for each condition. The coated or uncoated β-TCP discs were sterilized by UV 
treatment for 15 min and placed in 24-well tissue polystyrene (TCPS) plates. SaOS-2 cells 
(80,000 cells/well) were seeded on the surface of the discs in McCoy’s cell culture medium 
(Invitrogen, Carlsbad, CA, USA) and incubated at 37 ºC for a week. Cell culture media was 
replaced at every 24 h. At 6 h, 24 h, 3 days and 7 days’ time point, cells were lysed with 300 
µL of M-PER® (Mammalian Protein Extraction Reagent, Thermo Scientific, Waltham, MA, 
USA). The cell number was evaluated using the Cytotoxicity Detection Kit LDH (Roche Ap- 
plied Science, Penzberg, Germany), according to the manufacturer’s instructions. The LDH 
activity was measured spectrophotometrically at 492 nm with PowerWave HT microplate 
reader (Bio-Tek Instruments, Inc.) 24. The results were expressed as a relative fold change 
compared to the cell number obtained on TCPS at 6 h (SaOS-2 cells). The cell viability was 
calculated following equation 2, where Abs is the measured absorbance for the samples (Abs 
sample) and the positive (AbsC+) and negative control (AbsC−), all the results have 
been normalized with respect to surface area of TCPS. 




Specimens were prepared for SEM observation by fixing the cells with 4% 
paraformaldehyde in PBS, and a sequence for dehydrating the cells was performed by 
immersing the samples in 50%, 70%, 90%, 96%, and 100% (v/v) ethanol during 15 min each 
step. As the final step, samples were immersed in HDMS overnight and carbon coated. 
2.11. Statistical Analysis 
The data were analysed using Student’s t-tests and one-way ANOVA Tables with Tukey’s 
multiple comparison tests in order to evaluate statistically significant differences between 
sample groups.  The differences were considered to be statistically significant when p<0.05. 
All statistical analysis was performed with Minitab 16TM software (Minitab, Inc., State 
College, PA). 
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3. Results 
3.1. Characterization of the plasma coatings on β-TCP 
Plasma polymer coatings were produced on β-TCP, based on the polymerization of 
Diglyme at low pressure. To assess the kind of polymer produced by the low temperature 
plasma process evaluated, FTIR was performed on a model Si flat surface (Figure 2). The 
hump observed at 3600 cm-1 can be attributed to adsorbed water, the other bands found were 
characteristic of polymers: Two weak bands at 2952 cm-1 and 2888 cm-1 which can be 
attributed to hydrocarbon stretching ʋ(C-H) in alkanes. A medium band at 1655 cm-1 and 
another at 1533 cm-1 may correspond to ʋ (C=O), and the shoulder at 1464 can probably be 
attributed to ʋ (C-O). The intense bands at 1218 cm-1 and 1055 cm-1 can probably be assigned 
to ʋ as(C-O) and ʋ s(C-O), respectively. 
Uncoated β-TCP is a hydrophilic and porous material, and therefore it quickly absorbs 
water, not allowing contact angle measurement (Table 1). Furthermore, PEG being a 
hydrophilic polymer, its coatings should display contact angles below 90º, as recorded here 
for some selected plasma treatments on Silicon wafer employed as flat model surface (Figure 
2). Surprisingly, this was not the case for the different plasma treatments evaluated on β- TCP 
(Table 1) which displayed contact angle values above 120º, except for the PP10 sample that 
still absorbed water (although more slowly than the pristine material). It is remarkable that 
with PP20, PP30 or PP40 the droplet was strongly pinned to the surface, not rolling off even 
if the sample was held vertical (photographs in Figure 3). 
Dynamic contact angles were also measured (Table 1), and allowed calculating hysteresis, 
which was high and similar in the three plasma coated samples. 
The modification in surface chemistry indicated by contact angles was confirmed by XPS, 
by measuring the elemental composition of the untreated and plasma-polymerized β- TCP 
(Table 2). The composition of untreated β-TCP copes very well with its theoretical 
concentration, with a Ca/P ratio of 1.48, and the presence of some C can be attributed to 
adsorbed ambient contamination or surface carbonates. The increase in C/O ratio following 
all plasma polymerization treatments indicates the presence of a polymer. The fact that Ca or 
P was no longer detected pointed to a thickness of the polymer layer above 10 nm (i.e. the 
typical depth of detection of XPS). Figure 4 shows the C1s spectra of the PP40 PEG-like 
coatings, with three peaks. The two peaks at lower binding energies are the most prominent 
ones and correspond to carbon species with C-C or C-H, and, C-O. The third peak at larger 
binding energy is mainly attributed to C=O. PP10, PP20 and PP30 showed very similar C1s 
spectra. Scanning electron micrographs (Figure 5, left) reflect the roughness and porosity of β-
TCP. Moreover, following plasma polymerization SEM images clearly show that the coating 
itself is very thin, not masking any topographic features of β-TCP. At the same time, focused 
ion beam (FIB-SEM) transversal sections allowed visualizing (Figure 5, right) and measuring 
(Figure 6) the thickness of the coating as a function of the total treatment time of the plasma 
polymerization process. 
Thickness ranged between ~10 nm for PP10 to close to ~38 nm for PP40, revealing 
increasing thickness with longer total plasma treatment times but not following a completely 
linear behaviour. 
3.2. Biological response 
February 16, 2018  
The changes in the wettability of the samples might affect the biological response of the 
material. Therefore, the cytocompatibility of the samples was evaluated through adhesion and 
proliferation assays (Figure 7). All PEG-like plasma-coated β-TCP samples displayed the 
same cell adhesion and proliferation than β-TCP for all conditions evaluated, with the sole 
exception of PP40, which showed slightly lower proliferation values at 1 and 7 days. 
Scanning electron micrographs (Figure 8) show cells attached on the surface of β-TCP at 
different time points (6 h & 3 days). The morphology of the cells on all bioceramics showed 
extended cells, with visible fillopodia, disregard of the presence or absence of the coating. 
3.3. Drug Release 
Two different antibiotics were incorporated to the β-TCP ceramics prior to plasma coating: 
ampicillin (AMP) and gentamicin (GENTA). Their release kinetics was investigated 
following USP pharmacopoeia protocols for 24 h (Figure 9) and it can be observed that each 
drug follows a different release profile. On the one hand, ampicillin follows a burst release 
within the first 2 h in which most of the drug loaded is released (Figure 9).  On the other hand, 
gentamicin follows a more progressive release during 24 h (Figure 9). Regarding the plasma 
coatings, it can be underlined that while for GENTA the total amount released decreases with 
the thicker plasma coating, the profile of release remains unaltered, for AMP slightly different 
profile is observed for the samples PP20-D, PP30-D and PP40-D, as shown in Figure 9. 
The final release percentage of both drugs was close to 100 % for the untreated β-TCP 
samples, while as plasma polymerization times were longer, the total release % progressively 
decreased by close to 20% (Table 3). The release kinetics was fitted to different models, being 
Kopcha’s model the one showing best fitting. Fitting of the release data to Kopcha’s model 
showed that the release kinetics are governed by diffusion phenomena, A/B being >1. 
3.4. Antibacterial properties 
The influence of plasma polymerization on the antibacterial activity of ampicillin and 
gentamicin was studied in a kinetic growth assay over 26 h (Figure 10). The growth activity 
of S. aureus was measured for plasma polymerized β-TCP with antibiotics (ampicillin; 
gentamicin): PP10-D, PP20-D, PP30-D, PP40-D and the bacterial growth in BHI medium 
was used as a control. It was observed that only the samples without antibiotic (bacterial 
suspension used as positive control, untreated β-TCP (UT) and 40 min plasma polymerized 
β-TCP (PP40) showed bacterial growth. On the contrary, samples loaded with antibiotics 
either untreated or coated with the plasma polymer coating resulted in the inhibition of 
bacterial growth. 
4. Discussion 
Plasma-polymerization is a versatile technique for the deposition of films with functional 
properties suitable for a wide range of applications [18] and in this work it was employed to 
coat β-TCP bioceramics. These biomaterials are excellent bone substitutes, and their intrinsic 
microporosity allows incorporation of drugs. However, control of drug release is complex and 
a new strategy has been evaluated. 
Plasma polymer coatings deposited on top of polymers have been shown to have excel- 
lent barrier properties allowing to delay and control drug release [24, 25]. For biomedical 
applications, the polymers selected need to be, of course, non-toxic and biocompatible. 
Moreover, plasma polymerization allows for a one-step dry coating of the substrates. This, in 
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the case of drug-loaded materials is an advantage in front of other methods such as ie. dip-
coating as it avoids loss of drug in the coating solution during the coating treatment.  
Conventional polyethylene glycol (PEG) or polyethylene oxide materials (repeating unit: 
-CH2CH2O-) are often defined as non-fouling but when they are synthesized by plasma 
processes the chemical structure of the polymer obtained might be very different, with a 
certain degree of cross-linking, and presence of other moieties (i.e. ester, carbonyl, carboxyl 
and hydrocarbon groups) [26]. 
The coatings obtained here were produced on β-TCP from Diglyme as precursor at low 
pressure in sequential treatments ranging from 10 to 40 min of total treatment time (Figure 
1).  The coatings obtained revealed characteristic FTIR bands of PEG - C-O groups and C-H 
(Figure 2). The C/O surface ratio of the coatings was calculated from XPS data (Table 2), 
being around 3.5 for the four different coatings evaluated. The stoichiometric C/O ratio of 
Diglyme is of 2, so the values obtained in this work indicate loss of oxygen moieties and 
increased cross-linking due to high fragmentation in the plasma as also found by E. Sardella 
et al. for similar plasma coatings obtained at high power on a polymeric substrate [26]. 
They designated this as “reduced PEG-character” in the plasma coatings contributed by 
cross-linking and oxygen loss from the Diglyme precursor.  This is in agreement with the 
peak fitting of C1s XPS spectra of PP40 (Figure 3) where the C-C, C-H component at 285.0 
eV is the most important component (relative fraction ~50%), closely followed by C-O 
(~45%) attesting for the high hydrocarbon nature of PEG-like coatings deposited here. High 
hydrocarbon nature (C-C, C-H being the most abundant groups) was also observed in other 
works [26, 27]. 
It is not surprising to find this reduced PEG character, as in general, plasma polymers have 
different properties than those fabricated by conventional polymerization: the plasma-
polymerized films are usually branched, highly cross-linked, insoluble, pinhole-free, and 
adhere well to most substrates [28, 29]. Due to these excellent properties, plasma- 
polymerized films have been utilized in a wide range of applications, such as protective 
coatings, biomedical materials, electronic and optical devices, adhesion promoters, etc. 
The thickness of the coatings obtained was above 10 nm in all cases as revealed by the 
fact that Ca and P were not detected by XPS and as confirmed by FIB-SEM cross-section 
imaging (Figure 5). The PEG-like layer thickness (Figure 6) progressively increased with the 
total plasma treatment time in a nearly linear trend. 
The surface structure of the β-TCP bioceramic evaluated in this work is highly complex 
with rough topography (Figure 6 top), where crystal grains and sintering necks can be 
observed. The plasma coating did not alter the topography of the surface and the pores were 
not covered with any of the coatings evaluated. The porosity of β-TCP and its hydrophilic 
chemistry led to fast water absorption, which did not allow contact angle measurement (Table 
1). For the shortest treatment PP10 the coating was probably partially uneven, and some areas 
remained partially uncoated, still allowing for water absorption. Following plasma treatments 
of a total of 20 min or more (PP20, PP30, PP40), the static contact angles of the surface of β-
TCP raised to values between 120 and 126º as observed in Labay et al. [20]. This is shocking, 
considering that usually PEG-coatings are hydrophilic (θs < 90º), as confirmed by the contact 
angle values measured on flat silicon surfaces (Figure 3) with the same plasma coatings which 
varied between 74 and 79º. 
Besides, dynamic contact angles were measured, which allowed calculating the contact 
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angle hysteresis. The contact angle hysteresis is a measure for how well a drop of liquid sticks 
to the surface [30]. The hysteresis in contact angle obtained (Table 1) was rather high and 
very similar for all samples, indicating that the surface was heterogeneous. Considering the 
complex surface topography of β-TCP this can be attributed to roughness. This high hysteresis 
values are characteristic of surfaces where the drop does not roll-off easily [31], as confirmed 
by the pictures in Figure 3 showing pinning of the drop to the surface. 
All this was indication of Wenzel’s behaviour [32, 33] occurring on the surface of plasma 
coated β-TCP (depicted in Figure 11). The Wenzel relation (cosθ* = r cosθ) predicts that 
roughness enhances wettability which allowed calculating the apparent surface to be of 
roughness (r) = 2.6 ± 0.4 for this bioceramic, and coping well with the SEM images (Figure 
5). Despite the great changes in surface chemistry altered wettability, the cytocompatibility 
was not compromised (Figure 8). Cell adhesion (6h of cell culture) to the surface of PEG-like 
coated β-TCP in all conditions evaluated was comparable to that of the UT sample. The same 
occurred for the proliferation of the cells, which was the same to that of naked β-TCP (except 
only for PP40 at 24h and 7 days, where a minor decrease in the number of cells was 
registered). 
Despite PEG being widely acknowledged for its antifouling properties, our polymer layer 
was deposited by plasma in such conditions that lead to rather different chemistry than 
conventional PEG (less amount of C-O groups, more crosslinking, presence of other moieties 
such as C=O) so it has a “reduced” PEG character. Similar results were found when seeding 
3T3 fibroblasts on flat surfaces plasma coated employing also Diglyme, where those 
conditions leading to reduced PEG character of the coating displayed suitable cell 
morphology, and homogeneous growth of the cells on the substrates with these characteristics, 
while no attachment at all was observed when PEG coatings were produced so the PEG 
character was retained and antifouling properties were ensured [26]. 
This is further confirmed by the SEM images on the cells adhered to β-TCP (Figure 8) at 
different time points, which are very well extended on the surface of β -TCP for all coatings, 
with visible fillopodia which reflect their good attachment to the surface. Many parameters 
influence cell behaviour on bioceramics [34], and parameters such as surface roughness, 
chemistry, solubility and crystallinity play a role.  It seems clear that the thin layer produced 
here had suitable chemistry allowing, among others the protein adhesion required for further 
cell attachment, and therefore produced the minimum alterations in the biological behaviour 
of the samples. 
Two different antibiotics were selected in this work:  gentamicin, a wide spectrum antibiotic 
that is widely employed in orthopaedics, and ampicillin, which was selected for its wide 
spectrum of action and as reference for comparison with previous works [20, 35]. Both 
antibiotics followed distinct drug release profiles (Figure 9): On the one hand, ampicillin 
displayed burst release in the 1st h of release from UT-D  β-TCP, and the stationary  stage was 
reached after only 7h. On the other hand, gentamicin followed a more progressive release from 
UT-D and β-TCP, without reaching the stationary stage at least in the 24 h timeframe evaluated. 
The recorded differences could be ascribed to the higher molecular weight and steric 
hindrance of gentamicin (Supplementary Material Figure S1), impairing the diffusion from 
the β-TCP matrix. 
The plasma coatings evaluated here in both cases induced a progressively reduced amount 
of drug released, following this order:  UT-D ≥ PP10-D > PP20-D > PP30-D ≥ PP40-D. 
This could be explained by two different phenomena: i) etching processes occurring on 
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the surface simultaneously to the plasma polymerization during plasma treatment, which 
might have eliminated a certain amount of the most superficial antibiotic adsorbed on the 
bioceramic; and ii) a barrier effect due to the polymer layer created. This copes well with the 
fact that lower amount was released when the plasma coating proceeded on for longer times 
(Figure 9). Fortunately, the reactivity with the plasma phase did not revert in a denaturation 
of the antibiotics, as all samples showed suitable inhibition of the Staphilococcus 
aureus bacterial growth (Figure 10).  In general, after plasma processes aimed at modulation 
of drug release, the drugs keep their activity, as has been shown for different drugs (from 
anticancer to antibiotics), and varied plasma polymerization processes works. 
Fitting of the release profiles to the Kopcha model indicates that the release occurring for 
both antibiotics clearly follows a diffusion mechanism (as shown by an A/B ratio >1). 
Of course, to further control release from the plasma coating – to get closer to the 2-3 
month sustained release required for treatment of osteomyelitis - thicker layers need to be 
produced, as shown for coatings on polymer films by Arefi-Khonsari et al. [36, 37] or in our 
case in bioceramics from previous work [38]. In fact, a certain reduction in the release rate 
was recorded in the release of ampicillin from the coatings obtained at longer plasma 
treatment times (PP20-D, PP30-D and PP40-D) as had also been observed in a previous work 
of the group evaluating the same drug for coatings produced in similar conditions [20]. As 
observed in that case, it is expected that longer treatments produce further reduction in the 
initial release rate due to increased cross-linking of the polymer. 
 
5. Conclusions 
Antibiotic-releasing bioceramics with adequate drug release profiles and eliciting suitable 
biological response are of great interest. Plasma polymerization of Diglyme on drug-loaded β-
Tricalcium Phosphate (β-TCP) allowed reducing drug release by a dry solvent-free method.  PEG-like 
polymer coatings with low retention of the PEG character were obtained on microporous β-
TCP. This avoided the typical antifouling properties of PEG coatings. Plasma 
polymerization time dependency was observed in the coating thickness (ranging from 10 
nm to 40 nm) which in turn was related to the total amount of drug released. In certain 
conditions the antibiotic release profile was modified. Ampicillin and gentamicin antibiotics 
retained their antimicrobial activity intact after being released from the β-TCP substrates, 
confirming the suitability of the technique for coating the drug-loaded ceramic matrices. 
Despite the polymer produced being hydrophilic in nature, unexpected surface hydrophobicity 
following Wenzel’s behaviour was found on β-TCP. This was due to the significant roughness 
of the surface of this bioceramic. Still, the good cytocompatibility of β-TCP (adhesion and 
proliferation of SaOS-2) remained unaltered. The research undertaken allowed unravelling 
the characteristics of plasma coatings on calcium phosphate ceramics and advancing towards 
the design of drug delivery matrices with suitable biological and microbiological behaviour. 
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Figure 1: Scheme of the experimental layout employed to obtain PEG-like coatings on β-TCP discs. Low pressure 
plasma: 1st activation of the surface by O2 plasma and 2nd plasma polymerization Ar as carrier with Diglyme 
monomer, with 10 min sequential treatments named as plasma polymerization for 10 min (PP10), 20 min (PP20), 
30 min (PP30) and 40 min (PP40).  




Figure 2: FTIR spectrum of the plasma polymer (PP40) obtained on Si wafer as model surface. 
 
Figure 3: Wettability of two plasma-polymerized substrates: silicon wafer (employed as flat model surface) and β-
TCP samples (UT and PP10 were not measurable due to hydrophilicity). Images of the droplet on the surface of 
PP40 with the sample lying flat, or held vertical.  





                                                                
 
 
Figure 4: C1s spectra and peak decomposition of the PEG-like plasma polymer coating on β-TCP 
for PP40. 
 




Figure 5:  Scanning Electron Micrographs of β-TCP untreated surfaces at two different magnifications (top) and 
of the surface of β-TCP at different polymerization conditions PP10 and PP40 (left column) with their 
corresponding transversal sections obtained by FIB (right column). Arrows indicate the polymer coatings. (Other 
plasma polymer coatings:  PP20, PP30 not shown). 
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Figure 6: Thickness of the PEG-like layer obtained by different plasma polymerization treatments on the surface 




Figure 7: SaOS-2 cells relative fold growth on untreated β-TCP and plasma-polymerized β-TCP at different cell 
culture times. (A indicates significant differences with respect to β-TCP, P >0.05). TCPS accounts for “Tissue 
culture polystyrene” which is taken as a positive control. 
 






Figure 8:  Scanning electron micrographs of untreated and plasma-coated β-TCP seeded with SaOS-2cells    
for either 6 h (left) or 72 h (right). 










Figure 9: Release kinetics of ampicillin and gentamicin (top) for 24 h, and total quantity released for both 
ampicillin and gentamicin (labelled with ¨D¨	for drug) for untreated and different treatments (bottom right). 
 




Figure 10: Continuous monitoring of the optical density of Staphilococcus Aureus bacterial suspensions in 
contact with ampicillin (AMP) and gentamicin (GENTA) loaded β- TCP ceramics either untreated (UT) or 
plasma polymerized (PP40, PP10-D, PP20-D, PP30-D and PP40-D) or the suitable controls (in contact with 
S.aureus growth activity during 26 h. 
 
 
Figure 11: Representation of the wetting behaviour of β-TCP bioceramics before and after plasma 
polymerization of PEG-like layers. 
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Table 1: Influence of polymerization conditions evaluated on β-TCP, static contact angle and Dynamic 
advancing and receding contact angles and contact angle hysteresis of β-TCP samples untreated (UT) or with 
different plasma treatments.  
Table 2:  Elemental composition (in percentage) and C/O atomic ratio obtained by XPS β-TCP samples with 





Table 3: Ampicillin or Gentamicin released percentage β-TCP discs after 24 h and kopcha kinetics for the 
release kinetics. 
 
 Atomic percentages (%) Atomic ratio 
Codes C1s O1s Ca2p P2p C/O 
UT 12.4 56.1 18.8 12.7 0.22 
PP10	 77.5 22.5 - - 3.44 
PP20	 77.3 22.7 - - 3.41 
PP30	 78.2 21.8 - - 3.59 
PP40	 77.7 22.3 - - 3.47 
	 tplasma
tot	(min)	 θs	(º)	 θadv	(º)	 θrec	(º)	 Δθ(º)	
UT	 0	 *	 *	 *	 -	
PP10	 10	 *	 *	 *	 -	
PP20	 20	 120.03	±	2.51	 128.92	±	1.04	 65.61	±	4.18	 63.31	
PP30	 30	 123.27	±	3.76	 125.32	±	3.42	 59.97	±		6.17	 65.35	
PP40	 40	 126.20	±	3.99	 119.45	±	1.83	 57.08	±	5.67	 62.37	
 Ampicillin Gentamicin 
Kopcha´s Kinetics Kopcha´s Kinetics 
AMP released 
(%) 




R2 A B A/B 
(>1) 
UT 99.6 ± 0.5 0.983 0.736 0.022 32.6 99.3±0.9 0.987 0.540 0.015 35.79 
PP10 99.8 ± 1.7 0.982 0.586 0.010 55.8 98.7 ± 2.1 0.986 0.512 0.015 33.70 
PP20 96.9 ± 1.3 0.994 0.499 0.012 39.0 88.1 ± 4.1 0.975 0.506 0.016 30.53 
PP30 96.2 ± 2.2 0.993 0.559 0.016 34.8 80.9 ± 6.7 0.970 0.475 0.016 29.73 
PP40 80.7 ± 8.0 0.997 0.458 0.011 39.7 78.9 ± 2.8 0.975 0.442 0.015 30.32 
